Arcus Biosciences Total Current Liabilities 2011-2026 | RCUS

Annual Total Current Liabilities Arcus Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
231 M	226 M	184 M	193 M	166 M	122 M	22.7 M	16.9 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
231 M	16.9 M	145 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Altimmune ALT	15 M	$ 3.47	3.89 %	$ 306 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
AgeX Therapeutics AGE	5.91 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	5.75 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	2.97 M	$ 0.6	-2.83 %	$ 6.87 M	Israel
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	37.7 M	$ 13.01	2.12 %	$ 784 M	USA
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Heron Therapeutics HRTX	96.1 M	$ 0.8	2.29 %	$ 133 M	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	14 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	1.52 B	$ 91.13	0.38 %	$ 17.8 B	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
Inovio Pharmaceuticals INO	42.6 M	$ 1.6	0.95 %	$ 35.5 M	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Denali Therapeutics DNLI	102 M	$ 21.15	4.86 %	$ 3.48 B	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	22.5 M	$ 4.3	1.3 %	$ 714 M	Canada
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	6.27 M	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	22.4 M	-	-	$ 123 M	USA
Deciphera Pharmaceuticals DCPH	100 M	-	-	$ 2.18 B	USA
Cardiff Oncology CRDF	16.4 M	$ 1.8	0.08 %	$ 120 M	USA